Generating trust via corporate reputation: the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Hochschulschrift/Dissertation Buch |
| Sprache: | Englisch Deutsch |
| Veröffentlicht: |
Berlin
wvb, Wiss. Verl. Berlin
2011
|
| Schlagwörter: | |
| Links: | http://deposit.dnb.de/cgi-bin/dokserv?id=3898506&prov=M&dok_var=1&dok_ext=htm http://www.wvberlin.com/programm/shop/einzelansicht/aktuell/generating-trust-via-corporate-reputation/27159724c57f9ec05ce1c0dfb282fcae/?tt_products[begin_at]=10 http://www.wvberlin.com/uploads/tx_ttproducts/datasheet/978-3-86573-634-5.pdf http://www.wvberlin.de/data/inhalt/renner.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024537504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| Umfang: | XVII, 215 S. graph. Darst. |
| ISBN: | 9783865736345 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV039688665 | ||
| 003 | DE-604 | ||
| 005 | 20170420 | ||
| 007 | t| | ||
| 008 | 111108s2011 gw d||| m||| 00||| eng d | ||
| 015 | |a 11,N43 |2 dnb | ||
| 016 | 7 | |a 1016186940 |2 DE-101 | |
| 020 | |a 9783865736345 |c Gb. : EUR 34.00 (DE), EUR 35.00 (AT) |9 978-3-86573-634-5 | ||
| 024 | 3 | |a 9783865736345 | |
| 035 | |a (OCoLC)775725384 | ||
| 035 | |a (DE-599)DNB1016186940 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 1 | |a eng |h ger | |
| 044 | |a gw |c XA-DE-BE | ||
| 049 | |a DE-M382 |a DE-92 | ||
| 082 | 0 | |a 363.1940688 |2 22/ger | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 084 | |a 330 |2 sdnb | ||
| 100 | 1 | |a Renner, Markus |e Verfasser |4 aut | |
| 240 | 1 | 0 | |a Vertrauensbildung durch Unternehmensreputation |
| 245 | 1 | 0 | |a Generating trust via corporate reputation |b the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations |c Markus Renner |
| 264 | 1 | |a Berlin |b wvb, Wiss. Verl. Berlin |c 2011 | |
| 300 | |a XVII, 215 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |a Zugl.: Basel, Univ., Diss., 2011 | ||
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Vertrauenswürdigkeit |0 (DE-588)4209886-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Produktempfehlung |0 (DE-588)4126361-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Qualität |0 (DE-588)4047966-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Qualität |0 (DE-588)4047966-3 |D s |
| 689 | 0 | 2 | |a Vertrauenswürdigkeit |0 (DE-588)4209886-5 |D s |
| 689 | 0 | 3 | |a Produktempfehlung |0 (DE-588)4126361-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 856 | 4 | 2 | |m X:MVB |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=3898506&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext |
| 856 | 4 | 2 | |m X:MVB |q text/html |u http://www.wvberlin.com/programm/shop/einzelansicht/aktuell/generating-trust-via-corporate-reputation/27159724c57f9ec05ce1c0dfb282fcae/?tt_products[begin_at]=10 |3 Ausführliche Beschreibung |
| 856 | 4 | 2 | |m X:MVB |q application/pdf |u http://www.wvberlin.com/uploads/tx_ttproducts/datasheet/978-3-86573-634-5.pdf |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m X:MVB |q text/html |u http://www.wvberlin.de/data/inhalt/renner.html |3 Kurzbeschreibung |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024537504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-024537504 | |
Datensatz im Suchindex
| _version_ | 1819337588031356928 |
|---|---|
| adam_text | IMAGE 1
TABLE OF CONTENTS
FIGURES XII
LIST OF TABLES XIV
ABBREVIATIONS XVI
A INTRODUCTION 1
1 SPECIFICATION OF TOPIC 2
2 STATEMENT OF PROBLEM 6
3 RESEARCH QUESTIONS AND COURSE OF RESEARCH 12
B MINIMIZING RISK THROUGH TRUST 17
1 RISK PERCEPTION AS CONTEXT OF RESEARCH WORK 17
1.1 RISKS AND UNCERTAINTY 17
1.2 THE CONCEPT OF PERCEIVED RISK 25
1.3 PERCEPTION OF RISK IN THE PHARMACEUTICAL CONTEXT 31
1.4 MANAGING PERCEIVED RISK 32
1.5 REDUCING UNCERTAINTY THROUGH TRUST 34
2 TRUST IN PHARMACEUTICAL CORPORATIONS 36
2.1 FORMATION AND IMPACT OF TRUST 36
2.1.1 TRUST FROM A SOCIOLOGICAL PERSPECTIVE 36
2.1.2 TRUST FROM A PSYCHOLOGICAL PERSPECTIVE 38
2.1.3 PERSPECTIVES ON TRUST FROM THE FIELD OF ECONOMICS 39
2.1.4 CENTRAL ELEMENTS OF TRUST 41
2.1.5 RECAPITULATION: EXPLANATORY APPROACHES FOR THE FORMATION OF TRUST
42
2.2 DEFINING THE CONCEPT OF TRUST 43
VII
BIBLIOGRAFISCHE INFORMATIONEN HTTP://D-NB.INFO/1016186940
DIGITALISIERT DURCH
IMAGE 2
CONTENTS
2.2.1 DEFINITION OF ATTITUDE 43
2.2.2 DEFINITION OF TRUST 46
2.3 SPECIFYING THE CONSTRUCT OF A TRUSTFUL ATTITUDE 49
2.3.1 STATE OF RESEARCH ON THE CONSTRUCT OF TRUST 49
2.3.2 CONCEPTUALIZATION AND OPERATIONALIZATION OF
TRUSTFUL ATTITUDE 51
2.4 TRUSTFUL BEHAVIORAL INTENTION 54
2.4.1 STATE OF RESEARCH ON TRUSTFUL BEHAVIORAL INTENTION 55
2.4.2 CONCEPTUALIZATION AND OPERATIONALIZATION OF TRUSTFUL BEHAVIORAL
INTENTION 56
3 CORPORATE REPUTATION AS DETERMINANT OF TRUST 58
3.1 REPUTATION AS DETERMINANT OF TRUST IN BUSINESS RELATIONSHIPS 58
3.2 MODES OF ACTION OF REPUTATION IN GENERATING TRUST 62
3.2.1 REPUTATION AS INFORMATION 63
3.2.2 REPUTATION AS PENALIZATION OPTION 63
4 SUMMARY 64
C CORPORATE REPUTATION FROM STAKEHOLDER PERSPECTIVE 67
1 DEFINING THE CONCEPT OF REPUTATION 67
2 STATE OF RESEARCH ON CORPORATE REPUTATION 72
2.1 SCIENTIFIC APPROACHES TO CORPORATE REPUTATION 72
2.2 REPUTATION RANKINGS IN THE MEDIA 79
2.3 CENTRAL FINDINGS ON THE STATE OF RESEARCH 86
3 SPECIFICATION AND OPERATIONALIZATION OF CORPORATE REPUTATION 89
3.1 SPECIFICATION AND OPERATIONALIZATION OF QUALITY OF PRODUCTS AND
SERVICES 93
VIII
IMAGE 3
CONTENTS
3.1.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT 93
3.1.2 HYPOTHESES ON QUALITY OF PRODUCTS AND SERVICES 95
3.1.3 OPERATIONALIZATION OF QUALITY OF PRODUCTS AND SERVICES 96
3.2 SPECIFICATION AND OPERATIONALIZATION OF INNOVATIVENESS 97
3.2.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT 97
3.2.2 HYPOTHESES ON INNOVATIVENESS 98
3.2.3 OPERATIONALIZATION OF INNOVATIVENESS 99
3.3 SPECIFICATION AND OPERATIONALIZATION OF MARKETING AND SALES
EFFECTIVENESS 100
3.3.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT
100
3.3.2 HYPOTHESES ON MARKETING AND SALES EFFECTIVENESS 101
3.3.3 OPERATIONALIZATION OF MARKETING AND SALES EFFECTIVENESS. 103
3.4 SPECIFICATION AND OPERATIONALIZATION OF MANAGEMENT QUALITY 104
3.4.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT
104
3.4.2 HYPOTHESES ON MANAGEMENT QUALITY 104
3.4.3 OPERATIONALIZATION OF MANAGEMENT QUALITY 105
3.5 SPECIFICATION AND OPERATIONALIZATION OF SOCIAL RESPONSIBILITY. 106
3.5.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT
106
3.5.2 HYPOTHESES ON SOCIAL RESPONSIBILITY 108
3.5.3 OPERATIONALIZATION OF SOCIAL RESPONSIBILITY 109
3.6 SPECIFICATION AND OPERATIONALIZATION OF TRANSPARENCY 110
IX
IMAGE 4
CONTENTS
3.6.1 THEORETICAL FOUNDATION AND VALIDATION IN
PHARMACEUTICAL CONTEXT 110
3.6.2 HYPOTHESES ON TRANSPARENCY 112
3.6.3 OPERATIONALIZATION OF TRANSPARENCY 112
3.7 SPECIFICATION AND OPERATIONALIZATION OF ETHICAL BUSINESS PRACTICE
113
3.7.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT
113
3.7.2 HYPOTHESES ON ETHICAL BUSINESS PRACTICE 115
3.7.3 OPERATIONALIZATION OF ETHICAL BUSINESS PRACTICE 115
3.8 SPECIFICATION AND OPERATIONALIZATION OF BUSINESS PERFORMANCE 116
3.8.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT
116
3.8.2 HYPOTHESES ON BUSINESS PERFORMANCE 117
3.8.3 OPERATIONALIZATION OF BUSINESS PERFORMANCE 119
3.9 SPECIFICATION AND OPERATIONALIZATION OF EMPLOYER ATTRACTIVENESS 119
3.9.1 THEORETICAL FOUNDATION AND VALIDATION IN PHARMACEUTICAL CONTEXT
119
3.9.2 HYPOTHESES ON EMPLOYER ATTRACTIVENESS 121
3.9.3 OPERATIONALIZATION OF EMPLOYER ATTRACTIVENESS 122
4 OVERVIEW: RESEARCH MODEL AND STUDY HYPOTHESES 122
D EMPIRICAL STUDY 127
1 METHODOLOGY AND PROCEDURE OF THE EMPIRICAL STUDY 127
1.1 BASIC APPROACHES OF STRUCTURAL EQUATION MODELS 128
X
IMAGE 5
CONTENTS
1.2 MEASUREMENT THEORY 131
1.3 QUALITY CRITERIA 133
1.4 PROCEDURE 139
2 DATA COLLECTION 141
3 RESULTS OF THE EMPIRICAL STUDY 146
3.1 ANALYSIS OF MEASUREMENT MODELS 146
3.1.1 ANALYSIS OF THE DIMENSIONS OF CORPORATE REPUTATION 146
3.1.2 ANALYSIS OF DISCRIMINANT VALIDITY 159
3.1.3 ANALYSIS OF ENDOGENOUS CONSTRUCTS 160
3.2 ANALYSIS OF STRUCTURAL MODELS 163
3.2.1 ANALYSIS OF THE STRUCTURAL MODEL FOR PHYSICIANS 163
3.2.2 ANALYSIS OF THE STRUCTURAL MODEL FOR
PATIENT ORGANIZATIONS 168
3.3 COMPARISON OF STRUCTURAL MODELS AND SYNOPSIS 173
E CONCLUDING DISCUSSION 179
1 SUMMARY OF STUDY RESULTS 179
2 IMPLICATIONS FOR SCIENCE 181
3 IMPLICATIONS FOR APPLIED REPUTATION MANAGEMENT 184
BIBLIOGRAPHY 189
XI
|
| any_adam_object | 1 |
| author | Renner, Markus |
| author_facet | Renner, Markus |
| author_role | aut |
| author_sort | Renner, Markus |
| author_variant | m r mr |
| building | Verbundindex |
| bvnumber | BV039688665 |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)775725384 (DE-599)DNB1016186940 |
| dewey-full | 363.1940688 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 363 - Other social problems and services |
| dewey-raw | 363.1940688 |
| dewey-search | 363.1940688 |
| dewey-sort | 3363.1940688 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie Wirtschaftswissenschaften |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02669nam a2200541 c 4500</leader><controlfield tag="001">BV039688665</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170420 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">111108s2011 gw d||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">11,N43</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1016186940</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783865736345</subfield><subfield code="c">Gb. : EUR 34.00 (DE), EUR 35.00 (AT)</subfield><subfield code="9">978-3-86573-634-5</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783865736345</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)775725384</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1016186940</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="1" ind2=" "><subfield code="a">eng</subfield><subfield code="h">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">363.1940688</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">330</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Renner, Markus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="240" ind1="1" ind2="0"><subfield code="a">Vertrauensbildung durch Unternehmensreputation</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Generating trust via corporate reputation</subfield><subfield code="b">the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations</subfield><subfield code="c">Markus Renner</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="b">wvb, Wiss. Verl. Berlin</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 215 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Zugl.: Basel, Univ., Diss., 2011</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Vertrauenswürdigkeit</subfield><subfield code="0">(DE-588)4209886-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Produktempfehlung</subfield><subfield code="0">(DE-588)4126361-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Qualität</subfield><subfield code="0">(DE-588)4047966-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Qualität</subfield><subfield code="0">(DE-588)4047966-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Vertrauenswürdigkeit</subfield><subfield code="0">(DE-588)4209886-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Produktempfehlung</subfield><subfield code="0">(DE-588)4126361-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=3898506&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://www.wvberlin.com/programm/shop/einzelansicht/aktuell/generating-trust-via-corporate-reputation/27159724c57f9ec05ce1c0dfb282fcae/?tt_products[begin_at]=10</subfield><subfield code="3">Ausführliche Beschreibung</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://www.wvberlin.com/uploads/tx_ttproducts/datasheet/978-3-86573-634-5.pdf</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://www.wvberlin.de/data/inhalt/renner.html</subfield><subfield code="3">Kurzbeschreibung</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024537504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024537504</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV039688665 |
| illustrated | Illustrated |
| indexdate | 2024-12-20T16:00:08Z |
| institution | BVB |
| isbn | 9783865736345 |
| language | English German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024537504 |
| oclc_num | 775725384 |
| open_access_boolean | |
| owner | DE-M382 DE-92 |
| owner_facet | DE-M382 DE-92 |
| physical | XVII, 215 S. graph. Darst. |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | wvb, Wiss. Verl. Berlin |
| record_format | marc |
| spellingShingle | Renner, Markus Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations Pharmazeutische Industrie (DE-588)4045696-1 gnd Vertrauenswürdigkeit (DE-588)4209886-5 gnd Produktempfehlung (DE-588)4126361-3 gnd Qualität (DE-588)4047966-3 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4209886-5 (DE-588)4126361-3 (DE-588)4047966-3 (DE-588)4113937-9 |
| title | Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations |
| title_alt | Vertrauensbildung durch Unternehmensreputation |
| title_auth | Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations |
| title_exact_search | Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations |
| title_full | Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations Markus Renner |
| title_fullStr | Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations Markus Renner |
| title_full_unstemmed | Generating trust via corporate reputation the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations Markus Renner |
| title_short | Generating trust via corporate reputation |
| title_sort | generating trust via corporate reputation the influence of pharmaceutical companies reputations on the recommendation behaviors of physicians and patient organizations |
| title_sub | the influence of pharmaceutical companies' reputations on the recommendation behaviors of physicians and patient organizations |
| topic | Pharmazeutische Industrie (DE-588)4045696-1 gnd Vertrauenswürdigkeit (DE-588)4209886-5 gnd Produktempfehlung (DE-588)4126361-3 gnd Qualität (DE-588)4047966-3 gnd |
| topic_facet | Pharmazeutische Industrie Vertrauenswürdigkeit Produktempfehlung Qualität Hochschulschrift |
| url | http://deposit.dnb.de/cgi-bin/dokserv?id=3898506&prov=M&dok_var=1&dok_ext=htm http://www.wvberlin.com/programm/shop/einzelansicht/aktuell/generating-trust-via-corporate-reputation/27159724c57f9ec05ce1c0dfb282fcae/?tt_products[begin_at]=10 http://www.wvberlin.com/uploads/tx_ttproducts/datasheet/978-3-86573-634-5.pdf http://www.wvberlin.de/data/inhalt/renner.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024537504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT rennermarkus vertrauensbildungdurchunternehmensreputation AT rennermarkus generatingtrustviacorporatereputationtheinfluenceofpharmaceuticalcompaniesreputationsontherecommendationbehaviorsofphysiciansandpatientorganizations |